Leveraging dose heterogeneity from radiopharmaceutical therapy enhances Lutetium-177 anti-tumor efficacy via increased immune response
Maya Takashima
Morris Laboratory
Spatial and Epigenetic Mechanisms of AAV2 Persistence
Rhiannon Abrahams
Majumder Laboratory